Psoriasis Association

Recent papers from Psoriasis Association

1. Upadacitinib for Palmoplantar Pustulosis: An Open-label, Assessor-blinded Feasibility Study Using Historic Control Data (JAKPPPOT).2026
2. Patients’ and clinicians’ perspectives on telemedicine to monitor patients on systemic treatment for psoriasis or atopic dermatitis - a mixed methods studyJournal of Dermatological Treatment · 2026
3. Global health and economic impact of expanding the WHO essential medicines list for psoriasis: a health economic modelling studyEClinicalMedicine · 2026
4. Efficacy differences of biologic agents targeting different pathways in obese patients with psoriasis: a systematic review and meta-analysisJournal of Dermatological Treatment · 2026
5. Real-life experience of tildrakizumab 200 mg in complex psoriatic patients: a case seriesFrontiers in Medicine · 2026
6. Economic Impact of Timely Systemic Treatment of Psoriatic Disease in Comorbidity Risk Reduction: Literature Review and (Early) Economic AssessmentDermatology and Therapy · 2026
7. Patient-Reported Well-Being in Value-Based Routine Care in Psoriatic Disease Using Tildrakizumab: 2-Year Data of the Phase IV POSITIVE StudyPsoriasis Targets and Therapy · 2026
8. P017 Patient perspectives of care for immune-mediated inflammatory diseases in ScotlandLara D. Veeken · 2026
9. International consensus on dose reduction of biologics for patients with psoriasis: The DR . Delphi studyJournal of the European Academy of Dermatology and Venereology · 2026
10. Barriers to optimal psoriasis care from patient and provider perspectives: A multinational surveyJournal of the European Academy of Dermatology and Venereology · 2026
11. Shaping the future of clinical trials through strategic foresightClinical Trials · 2026
12. S3 Guideline for the Treatment of Psoriasis vulgaris, adapted from EuroGuiDerm – part 2: Specific clinical and comorbid situationsJDDG Journal der Deutschen Dermatologischen Gesellschaft · 2026
13. Building the foundations for an international patient‐centred outcomes set for psoriasis: A scoping studyJournal of the European Academy of Dermatology and Venereology · 2026
14. Exploring clusters based on ultrasound-detected inflammation in patients with psoriatic arthritis: a post-hoc analysis from the ULTIMATE trialBMC Musculoskeletal Disorders · 2026
15. Efficacy of an intervention to reduce stigma towards people with skin diseases among health and body care professionals – a randomized controlled trialJDDG Journal der Deutschen Dermatologischen Gesellschaft · 2026
16. S3 Guideline for the treatment of psoriasis vulgaris, adapted from EuroGuiDerm – part 1: Treatment recommendations and monitoringJDDG Journal der Deutschen Dermatologischen Gesellschaft · 2026
17. Remote monitoring in chronic immune-mediated inflammatory diseases: A systematic review of active and passive approachesJAAD International · 2025
18. Patient Experiences on the Diagnosis, Management, and Burden of Generalized Pustular Psoriasis: An International Web Survey and Qualitative Interview StudyJournal of Psoriasis and Psoriatic Arthritis · 2025
19. Patient Experiences on the Diagnosis, Management, and Burden of Generalized Pustular Psoriasis: An International Web Survey and Qualitative Interview StudyJournal of Psoriasis and Psoriatic Arthritis · 2025
20. Joint position statement from the National Psoriasis Foundation Medical Board and the International Psoriasis Council on routine testing for latent tuberculosis infection prior to and during treatment of psoriasis patients with interleukin 17 or interleukin 23 inhibitorsJournal of the American Academy of Dermatology · 2025